Beam Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	294.94	281.97	435.9	232.77	559.99
Short-Term Investments	950.27	568.77	753.98	845.37	405.65
Cash & Short-Term Investments	1,245	850.74	1,190	1,078	965.65
Cash Growth	46.37%	-28.50%	10.36%	11.65%	222.24%
Other Receivables	-	-	-	-	300
Total Trade Receivables	-	-	-	-	300
Other Current Assets	23.48	27.41	21.17	14.76	7.36
Total Current Assets	1,269	878.15	1,211	1,093	1,273
Net Property, Plant & Equipment	205.18	216.28	237.81	234.13	186.98
Other Long-Term Assets	7.31	9.4	10.87	14.69	14.47
Total Assets	1,481	1,104	1,460	1,342	1,474
Accounts Payable	10.23	3.87	1.62	9.03	7.47
Accrued Expenses	55.27	47.47	111.66	49.91	67.66
Current Portion of Long-Term Debt	-	-	-	-	2.29
Current Portion of Leases	14.36	13.47	12.78	10.38	7.54
Unearned Revenue	6.66	108.86	68.71	135.97	86.27
Other Current Liabilities	10.41	8.4	10.8	18.3	42.2
Total Current Liabilities	96.94	182.07	205.57	223.6	213.44
Long-Term Debt	-	-	-	-	3.01
Long-Term Leases	139.76	147.96	159.91	168.63	134.81
Other Long-Term Liabilities	6.13	40.26	112.91	216.02	296.46
Total Long-Term Liabilities	145.88	188.21	272.82	384.65	434.28
Total Liabilities	242.82	370.28	478.39	608.24	647.72
Common Stock	1.02	0.84	0.82	0.71	0.68
Additional Paid-in Capital	2,877	2,299	2,170	1,793	1,594
Accumulated Other Comprehensive Income	1.11	0.68	0.6	-2.43	-0.05
Retained Earnings	-1,641	-1,567	-1,190	-1,057	-768.27
Shareholders' Equity	1,238	733.55	981.33	733.47	826.74
Total Liabilities & Equity	1,481	1,104	1,460	1,342	1,474
Total Debt	154.12	161.43	172.69	179.01	147.64
Net Cash (Debt)	1,091	689.32	1,017	899.13	818
Net Cash Growth	58.29%	-32.23%	13.13%	9.92%	325.98%
Net Cash Per Share	11.03	8.37	13.18	12.84	12.74
Book Value	1,238	733.55	981.33	733.47	826.74
Book Value Per Share	12.52	8.91	12.72	10.48	12.87
Tangible Book Value	1,238	733.55	981.33	733.47	826.74
Tangible Book Value Per Share	12.52	8.91	12.72	10.48	12.87

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q